Transcriptomic Evidence of Immune Modulation in Subjects With Chronic Trypanosoma cruzi Infection.

Autor: Ros-Lucas A; ISGlobal, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.; El Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Gabaldón-Figueira JC; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain., Martínez-Peinado N; ISGlobal, Barcelona, Spain., Losada-Galván I; ISGlobal, Barcelona, Spain., Posada E; ISGlobal, Barcelona, Spain., Escabia E; ISGlobal, Barcelona, Spain., Martín-Mur B; National Center for Genomic Analysis-Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Gut M; National Center for Genomic Analysis-Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Esteve-Codina A; National Center for Genomic Analysis-Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Gascón J; ISGlobal, Barcelona, Spain.; El Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Pinazo MJ; El Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Drugs for Neglected Diseases Initiative, Geneva, Switzerland., Alonso-Padilla J; ISGlobal, Barcelona, Spain.; El Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Dec 16; Vol. 230 (6), pp. 1518-1528.

Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection.

Autor: Gabaldón-Figueira JC; ISGlobal, Barcelona, Spain. juancarlos.gabaldon@isglobal.org.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain. juancarlos.gabaldon@isglobal.org.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain. juancarlos.gabaldon@isglobal.org., Ros-Lucas A; ISGlobal, Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Martínez-Peinado N; ISGlobal, Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain.; Secció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain., Blackburn G; MVLS Shared Research Facilities, University of Glasgow, Glasgow, G12 8QQ, Scotland., Losada-Galvan I; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain., Posada E; ISGlobal, Barcelona, Spain., Ballart C; ISGlobal, Barcelona, Spain.; Secció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain., Escabia E; ISGlobal, Barcelona, Spain., Capellades J; Institut d'Investigació Sanitària Pere Virgili (IISPV), Metabolomics Platform, Reus, Spain.; Department of Electronic Engineering, Universitat Rovira i Virgili, Tarragona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Yanes O; Institut d'Investigació Sanitària Pere Virgili (IISPV), Metabolomics Platform, Reus, Spain.; Department of Electronic Engineering, Universitat Rovira i Virgili, Tarragona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Pinazo MJ; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain.; Drugs for Neglected Diseases Initiative (DNDi), Rio de Janeiro, Brazil., Gascón J; ISGlobal, Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain., Alonso-Padilla J; ISGlobal, Barcelona, Spain. julio.a.padilla@isglobal.org.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain. julio.a.padilla@isglobal.org.

Publikováno v: Parasites & vectors [Parasit Vectors] 2024 Nov 09; Vol. 17 (1), pp. 459. Date of Electronic Publication: 2024 Nov 09.

A guide for the generation of repositories of clinical samples for research on Chagas disease.

Autor: Martínez-Peinado N; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; Secció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain., Gabaldón-Figueira JC; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain., Rodrigues Ferreira R; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (LITEB-IOC/Fiocruz), Rio de Janeiro, Brazil.; Laboratory of Applied Genomics and Bioinnovations, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, (LAGABI-IOC/Fiocruz), Rio de Janeiro, Brazil., Carmen Thomas M; Instituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), PTS-Granada, Granada, Spain., López MC; Instituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), PTS-Granada, Granada, Spain., Cremonini Araújo-Jorge T; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (LITEB-IOC/Fiocruz), Rio de Janeiro, Brazil., Alarcón de Noya B; Instituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela., Berón S; Fundación Mundo Sano, Buenos Aires, Argentina., Ramsey J; Centro Regional de Investigación en Salud Pública (CRISP), Instituto Nacional de Salud Pública (INSP), Tapachula, Chiapas, México., Losada Galván I; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain., Schijman AG; Laboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular 'Dr. Héctor N. Torres' - INGEBI-CONICET, Buenos Aires, Argentina., González Martínez A; Departamento de Investigación, Salvando Latidos A.C., Guadalajara, Mexico.; Departamento de Investigación, Instituto Cardiovascular de Mínima Invasión (ICMI), Guadalajara, Mexico., Mariano Ruiz A; Instituto Nacional de Parasitología 'Dr Mario Fatala Chaben' ANLIS MALBRÁN, Ministerio de Salud, Buenos Aires, Argentina.; CONICET, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina., Rojas G; Universidad Mayor de San Simón and Fundación CEADES, Cochabamba, Bolivia., Magalhães Saraiva R; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brasil., Noya-González O; Instituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.; Cátedra de Parasitología, Escuela ¨Luís Razetti' Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.; Centro para Estudios Sobre Malaria, Instituto de Altos Estudios 'Dr. Arnoldo Gabaldón', Ministerio del Poder Popular para la Salud (MPPS), Caracas, Venezuela., Gómez A; Fundación Mundo Sano, Buenos Aires, Argentina., Maldonado RA; Department of Biological Sciences, The University of Texas at El Paso, El Paso, Texas, United States of America., Pinto J; Universidad Mayor de San Simón and Fundación CEADES, Cochabamba, Bolivia., Torrico F; Universidad Mayor de San Simón and Fundación CEADES, Cochabamba, Bolivia., Scandale I; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland., Agüero F; Instituto de Investigaciones Biotecnológicas (IIB)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), San Martín, Buenos Aires, Argentina.; Escuela de Bio y Nanotecnologías (EByN), Universidad de San Martín (UNSAM), San Martín, Buenos Aires, Argentina., Pinazo MJ; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain., Gascón J; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brasil., Alonso-Padilla J; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Aug 15; Vol. 18 (8), pp. e0012166. Date of Electronic Publication: 2024 Aug 15 (Print Publication: 2024).

Cooperation for malaria control and elimination in the Guiana Shield.

Autor: Sanna A; French West Indies-French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France. Electronic address: a.sanna33@gmail.com., Suárez-Mutis M; Laboratory of Parasitic Diseases, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; International Joint Laboratory Sentinela, Fundação Oswaldo Cruz, University of Brasília, French National Research Institute for Sustainable Development, Rio de Janeiro, Brazil., Lambert Y; French West Indies-French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France., Carvalho L; Santé Publique France, Cayenne, French Guiana, France., Cairo H; National Malaria Program, Ministry of Health, Paramaribo, Suriname., Cox H; Vector-Borne Diseases Unit, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago., de Bort C; Regional Health Agency, Cayenne, French Guiana, France., Gomes do Socorro Mendonça M; Secretariat of Health Surveillance of the State of Amapá, Macapá, Brazil., Forero-Peña DA; Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela; Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolívar, Venezuela., Gabaldón-Figueira JC; Barcelona Institute for Global Health, Hospital Clinic, University of Barcelona, Barcelona, Spain., Grillet ME; Laboratory of Biology of Vectors and Parasites, Institute of Zoology and Tropical Ecology, Faculty of Sciences, Central University of Venezuela, Caracas, Venezuela., Klein F; Directorate General for Health, Ministry of Health and Prevention, Paris, France., Lazarus C; Directorate General for Health, Ministry of Health and Prevention, Paris, France., Lazrek Y; Laboratory of Parasitology, Pasteur Institute in French Guiana, Cayenne, French Guiana, France., Louzada J; Department of Nursing Science, Federal University of Roraima, Boa Vista, Brazil., Malafaia D; Vigifronteiras Program, Fundação Oswald Cruz, Rio de Janeiro, Brazil; Chamber of Deputies, National Congress, Brasília, Brazil., Marchesini P; Overall Coordination of Surveillance of Zoonoses and Vector-Borne Diseases, Ministry of Health of Brazil, Brasília, Brazil., Musset L; Laboratory of Parasitology, Pasteur Institute in French Guiana, Cayenne, French Guiana, France., Oliveira-Ferreira J; Laboratory of Immunoparasitology, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Peterka C; Coordination of Malaria Elimination, Ministry of Health of Brazil, Brasília, Brazil., Rousseau C; Division of Decentralized Primary Care Centers, Cayenne Hospital, Cayenne, French Guiana, France., Roux E; ESPACE-DEV, French National Research Institute for Sustainable Development, University of Montpellier, University of the French West Indies, University of French Guiana, University of Reunion Island, and University of Perpignan Via Domitia, Montpellier, France; International Joint Laboratory Sentinela, Fundação Oswaldo Cruz, University of Brasília, French National Research Institute for Sustainable Development, Rio de Janeiro, Brazil., Villegas L; Asociación Civil Impacto Social, Tumeremo, Venezuela., Vreden S; Foundation for the Advancement of Scientific Research in Suriname, Paramaribo, Suriname., Wiedner-Papin S; Regional Health Agency, Cayenne, French Guiana, France., Laporta GZ; Faculty of Medicine of ABC, Federal University of ABC, Santo André, Brazil., Hiwat H; National Malaria Program, Ministry of Health, Paramaribo, Suriname., Douine M; French West Indies-French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 May; Vol. 12 (5), pp. e875-e881.

Topical repellents for malaria prevention

Autor: Wagah, MG, Gabaldón Figueira, JC, Maia, MF

Publikováno v: Cochrane Database Syst Rev

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effect of topical repellents alone or in combination with other background interventions for reducing malaria incidence in high-risk an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567cc7a763c1cd2d51c17a7aa0fc22be
https://ora.ox.ac.uk/objects/uuid:9df2b347-0f69-4772-b212-66d38a496008